Curated News
By: NewsRamp Editorial Staff
November 16, 2026

Viromed Medical AG Appoints Christian Strauch to Management Board as Uwe Perbandt Resigns

TLDR

  • Viromed Medical AG appointed Christian Strauch to its Management Board to drive its next growth phase using his sales expertise.
  • Viromed Medical AG's Supervisory Board appointed Christian Strauch to the Management Board effective November 16, 2026, succeeding founder Uwe Perbandt, who resigned for personal reasons.
  • Viromed Medical AG's leadership change supports advancing cold plasma technology to help more people and save lives.
  • Christian Strauch, who built apo-rot to 450 employees and EUR 100 million revenue, now joins Viromed Medical AG's Management Board.

Impact - Why it Matters

The leadership transition at Viromed Medical AG comes at a pivotal moment for the company. With its cold plasma technology now market-ready, Viromed is poised for a growth phase that could significantly expand the adoption of this innovative medical treatment. Christian Strauch's extensive experience in scaling healthcare businesses, particularly his success with apo-rot and his role in building pharmedix, positions him well to drive commercialization and operational expansion. For stakeholders, this change signals continuity and strategic intent: the founder's legacy is being handed to a seasoned executive who can leverage Viromed's technological edge to capture larger market share. The move also underscores the increasing importance of cold plasma technology in medicine, which has the potential to improve patient outcomes and save lives. As Viromed continues to grow, its success could further validate cold plasma as a mainstream medical solution, benefiting patients and investors alike.

Summary

Viromed Medical AG, a German medical technology company specializing in cold plasma technology, has announced a significant change to its Management Board. Christian Strauch has been appointed as a new member effective November 16, 2026, for a term lasting until October 31, 2029. Simultaneously, Uwe Perbandt, the company's founder and CEO, has resigned from his position effective December 31, 2026, citing personal reasons. The transition is described as taking place by mutual agreement, with Perbandt expressing full confidence in his successor, whom he calls his preferred candidate.

Dr. Thomas Gutschlag, Chairman of the Supervisory Board, praised Perbandt for his tremendous commitment in developing Viromed into an internationally leading enterprise in cold plasma technology. He noted that with the technology now market-ready, the company stands at the threshold of an exciting growth phase, and Strauch's well-founded sales expertise makes him the ideal candidate to help shape this phase successfully. Perbandt, in turn, expressed pride in building Viromed with a dedicated team and emphasized that cold plasma technology allows the company to help many people and save lives, making it crucial that his life's work be continued in the best possible way.

Christian Strauch brings over twenty years of experience in building and scaling healthcare companies. He is currently Managing Director of pharmedix GmbH, a Viromed subsidiary, and previously built the mail-order pharmacy apo-rot, growing it to 450 employees and up to EUR 100 million in annual revenue before overseeing the sale of its mail-order division to the Zur Rose Group or DocMorris. He also led the integration of acquisitions as Managing Director of two DocMorris subsidiaries, initiated the acquisition of medpex, restructured the group's procurement, founded two pharmaceutical wholesalers, and has been building the Vameda Group since 2020. Viromed Medical AG, listed on the stock exchange since October 2022, focuses on the distribution of innovative cold plasma technology for medical applications through its wholly owned subsidiary Viromed Medical GmbH, with a broad customer base in the DACH region and beyond. For more information, visit www.viromed-medical-ag.de.

Source Statement

This curated news summary relied on content distributed by NewMediaWire. Read the original source here, Viromed Medical AG Appoints Christian Strauch to Management Board as Uwe Perbandt Resigns

Blockchain registration record for this content